• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于 4-喹诺酮-3-羧酸基序的研究。6. 7-取代喹诺酮-3-羧酰胺衍生物作为大麻素受体高亲和力配体的合成和药理学评价。

Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors.

机构信息

Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via A. Moro, 53100 Siena, Italy.

出版信息

Eur J Med Chem. 2012 Dec;58:30-43. doi: 10.1016/j.ejmech.2012.09.035. Epub 2012 Oct 3.

DOI:10.1016/j.ejmech.2012.09.035
PMID:23085772
Abstract

Within our studies on structure-activity relationships of 4-quinolone-3-carboxamides as cannabinoid ligands, a new series of compounds characterized by a fluoro or phenylthio group at 7-position and different substituents at N1 and carboxamide nitrogen were synthesized and evaluated for their binding ability to cannabinoid type 1 (CB1) and type 2 (CB2) receptors. Most of the compounds showed affinity for one or both cannabinoid receptors at nanomolar concentration, with K(i)(CB1) and K(i)(CB2) values ranging from 2.45 to >10,000 nM and from 0.09 to 957 nM, respectively. The N-(3,4-dichlorobenzyl)amide derivatives 27 and 40 displayed relatively low affinity, but high selectivity towards the CB1 receptor. Compounds 4 and 40, a CB2 and a CB1 ligand, respectively, behaved as partial agonists in the [(35)S]GTPγS assay. They showed very low permeability through (MDCK-MDR1) cells and might, therefore, represent possible lead structures for further optimization in the search for cannabinoid ligands unable to cross the blood-brain barrier.

摘要

在我们对 4-喹诺酮-3-羧酰胺作为大麻素配体的结构-活性关系的研究中,合成了一系列新的化合物,其特征是在 7-位具有氟或苯硫基以及在 N1 和羧酰胺氮上具有不同取代基。这些化合物的结合能力被评估为对大麻素类型 1(CB1)和类型 2(CB2)受体。大多数化合物在纳摩尔浓度下对一种或两种大麻素受体表现出亲和力,Ki(CB1)和 Ki(CB2)值分别为 2.45 至>10,000 nM 和 0.09 至 957 nM。N-(3,4-二氯苄基)酰胺衍生物 27 和 40 对 CB1 受体表现出相对较低的亲和力,但具有较高的选择性。化合物 4 和 40,分别为 CB2 和 CB1 配体,在[(35)S]GTPγS 测定中表现为部分激动剂。它们在 (MDCK-MDR1) 细胞中的通透性非常低,因此可能代表进一步优化以寻找不能穿过血脑屏障的大麻素配体的潜在先导结构。

相似文献

1
Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors.关于 4-喹诺酮-3-羧酸基序的研究。6. 7-取代喹诺酮-3-羧酰胺衍生物作为大麻素受体高亲和力配体的合成和药理学评价。
Eur J Med Chem. 2012 Dec;58:30-43. doi: 10.1016/j.ejmech.2012.09.035. Epub 2012 Oct 3.
2
Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.新型4-氧代-1,4-二氢喹啉-3-甲酰胺衍生物作为新型CB2大麻素受体激动剂:合成、药理性质及分子模拟
J Med Chem. 2006 Jan 12;49(1):70-9. doi: 10.1021/jm050467q.
3
Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo.4-喹诺酮-3-羧酸基序的研究。2. 具有体内镇痛活性的强效和选择性大麻素-2受体激动剂的合成及构效关系。
J Med Chem. 2008 Aug 28;51(16):5075-84. doi: 10.1021/jm800552f. Epub 2008 Aug 5.
4
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.基于三维定量构效关系分析的大麻素受体 2 高选择性配体的合理设计。
Eur J Med Chem. 2011 Feb;46(2):547-55. doi: 10.1016/j.ejmech.2010.11.034. Epub 2010 Nov 27.
5
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.新型烷基间苯二酚大麻素受体配体的结构-亲和力关系及药理学特性:一种双重大麻素受体/TRPA1通道激动剂的鉴定
Bioorg Med Chem. 2014 Sep 1;22(17):4770-83. doi: 10.1016/j.bmc.2014.07.006. Epub 2014 Jul 12.
6
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as selective CB(2) cannabinoid receptor ligands: structural investigations around a novel class of full agonists.7-氧代-[1,4]恶嗪并[2,3,4-ij]喹啉-6-甲酰胺类化合物作为选择性 CB(2) cannabinoid 受体配体:新型全激动剂类化合物的结构研究。
J Med Chem. 2012 Jul 26;55(14):6608-23. doi: 10.1021/jm300763w. Epub 2012 Jul 11.
7
Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.香豆素衍生物作为大麻素受体拮抗剂和反向激动剂的合成及药理学评价
Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. doi: 10.1016/j.bmc.2009.02.027. Epub 2009 Feb 21.
8
Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands.对 4-喹诺酮-3-羧酸基序的研究。3. 6-取代的 4-喹诺酮-3-羧酰胺作为高度选择性大麻素-2 受体配体的合成、结构-亲和力关系和药理学特征。
J Med Chem. 2010 Aug 26;53(16):5915-28. doi: 10.1021/jm100123x.
9
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility.4-喹诺酮-3-羧酸基序的研究。7. 4-喹诺酮-3-甲酰胺和4-羟基-2-喹诺酮-3-甲酰胺作为具有改善水溶性的高亲和力大麻素受体2(CB2R)配体的合成及药理学评价。
J Med Chem. 2016 Feb 11;59(3):1052-67. doi: 10.1021/acs.jmedchem.5b01559. Epub 2016 Jan 26.
10
1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists.1-二苯甲基-3-苯基脲和1-二苯甲基-3-苯基硫脲衍生物:CB1大麻素受体反向激动剂中的新型模板
J Med Chem. 2005 Nov 17;48(23):7486-90. doi: 10.1021/jm0503906.

引用本文的文献

1
Synthesis, Structure-Activity Relationships, Radiofluorination, and Biological Evaluation of [F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET.[F]RM365 的合成、构效关系、放射性标记及作为正电子发射断层扫描(PET)脑内人源大麻素受体 2(CB2R)显像剂的生物学评价
J Med Chem. 2023 Oct 26;66(20):13991-14010. doi: 10.1021/acs.jmedchem.3c01035. Epub 2023 Oct 10.
2
Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor.系统修饰 7-羟基-5-氧代吡唑并[4,3-]吡啶-6-甲酰胺支架的取代模式,发现了对大麻素 2 型受体具有高亲和力和选择性的新型配体。
Molecules. 2023 Jun 24;28(13):4958. doi: 10.3390/molecules28134958.
3
In Silico Multi-Target Approach Revealed Potential Lead Compounds as Scaffold for the Synthesis of Chemical Analogues Targeting SARS-CoV-2.计算机辅助多靶点方法揭示了潜在的先导化合物作为合成靶向SARS-CoV-2化学类似物的支架。
Biology (Basel). 2022 Mar 18;11(3):465. doi: 10.3390/biology11030465.
4
Study on the regioselectivity of the N-ethylation reaction of -benzyl-4-oxo-1,4-dihydroquinoline-3-carboxamide.苄基-4-氧代-1,4-二氢喹啉-3-甲酰胺N-乙基化反应的区域选择性研究。
Beilstein J Org Chem. 2019 Feb 12;15:388-400. doi: 10.3762/bjoc.15.35. eCollection 2019.
5
Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases.大麻素化合物治疗与神经元活动相关疾病的结构-活性关系。
Molecules. 2018 Jun 25;23(7):1526. doi: 10.3390/molecules23071526.
6
Assembly of a mononuclear ferrous site using a bulky aldehyde-imidazole ligand.使用一种庞大的醛-咪唑配体组装单核亚铁位点。
Inorganica Chim Acta. 2017 Aug 1;464:152-156. doi: 10.1016/j.ica.2017.05.028. Epub 2017 May 13.
7
Mastering tricyclic ring systems for desirable functional cannabinoid activity.掌握三环环系统以获得理想的功能性大麻素活性。
Eur J Med Chem. 2013 Nov;69:881-907. doi: 10.1016/j.ejmech.2013.09.038. Epub 2013 Sep 29.